Come on lasers, do honestly believe that or are you reluctant to agree because of how adamantly you argued with me that MCC would not be the abstract and that it was obviously Melanoma. Any respectable company would not conduct themselves that way and that move would be way out of character for ONCS. With ASCO's policies there is NO DOUBT ONCS sent them something different from ASGCT.
SO.....if Melanoma went to ASGCT then that leaves one data set, that was supposed to be released the end of 2013, which we never got any information about. The data that could bring Orphan designation to ONCS....MCC.
Hey, I may be wrong. But suggesting that they sent two equal abstracts to play the odds game???????? Sorry , no chance of that!
News 
Market Data 
Discover 
